Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-29

Clinical Trial Update: Safety Study of Nicardipine to Treat Cerebral Vasospasm [Phase 2]

View source ↗

Summary

Terminated Phase 2 safety study evaluating nicardipine for treating cerebral vasospasm; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine (nicardipine)

Snippet

Sponsor: University of Florida | Conditions: Cerebral Vasospasm | Phase 2 | Status: TERMINATED | Results posted: 2014-08-29